Variations in the electrostatic landscape of class II human leukocyte antigen molecule induced by modifications in the Myelin basic protein peptide: A theoretical approach

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Agudelo, William A ^a,b   Galindo, Johan F ^a,b   Ortiz, Marysol ^a,b   Villaveces, José L ^b,c   Daza, Edgar E ^b   Patarroyo, Manuel E ^a  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c UNIVERSIDAD DE LOS ANDES   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; HLA D ANTIGEN; LIGAND; PEPTIDE;

ARTICLE; COMPLEX FORMATION; DRUG DESIGN; ELECTRIC POTENTIAL; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; QUANTUM CHEMISTRY; THEORETICAL STUDY; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; METABOLISM; STATIC ELECTRICITY; THEORETICAL MODEL;

BINDING SITES; COMPUTER SIMULATION; HLA-D ANTIGENS; LIGANDS; MODELS, MOLECULAR; MODELS, THEORETICAL; MYELIN BASIC PROTEINS; PEPTIDES; STATIC ELECTRICITY;

EID: 58349083718     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004164     Document Type: Article

References (37)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434: 214-217.
2. Patarroyo ME, Cifuentes G, Vargas LE, Rosas JE (2004) Structural Modifications Enable Conserved Peptides to fit into MHC Molecules thus Inducing Protection agaist Malaria. ChemBiochem 5: 480-498.
3. Patarroyo ME, Cifuentes G, Baquero J (2006) Comparative molecular and three-dimensional analysis of the peptide-MHC II binding region in both human and Aotus MHC-DRB molecules confirms their usefulness in antimalarial vaccine development. Immunogenetics 58: 598-606.
4. García JE, Puentes A, Patarroyo ME (2006) Development Biology of Sporozoite-Host Interactions in P. Falciparum malaria: Implications in vaccine desing. Clin Microbiol Rev 19: 686-707.
5. Patarroyo ME, Cifuentes G, Bermúdez A, Patarroyo MA (2008) Strategies for developing multi-epitope, subunit-based, chemically-synthesized antimalarial vaccines. J Cell Mol Med 12: 1-25.
6. Patarroyo ME, Patarroyo MA (2008) Emerging Rules for Subunit-Based, Multiantigenic, Multistage Chemically Synthesized Vaccines. Acc Chem Res 41: 357-387.
7. Cifuentes G, Bermúdez A, Rodriguez R, Patarroyo MA, Patarroyo ME (2008) Shifting the polarity of some Critical Residues in Malarial Peptides Binding to Host Cells is a Key Factor in Greaking Conserved Antigens Code of Silence. Med Chem 4: 1-18.
8. Rodríguez LE, Curtidor H, Valbuena J, Puentes A, Vera R, et al. (2008) Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design. Chemical Reviews; In Press.
9. Reche PA, Reinherz EL (2003) Sequence Variability Analysis of Human Class I and Class II MHC Molecules: Functional and Structural Correlates of Amino Acid Polymorphisms. J Mol Biol 331: 623-641.
10. Marsh SG, Parham P, Barber LD (2000) The HLA Facts Book. London: Academic Press.
11. Svensson A, Setterblad N, Pihlgren U, Rask L, Andersson G (1996) Evolutionary relationship between human major histocompatibility complex HLA-DR haplotypes. Immunogenetics 43: 304-314.
12. Andersson G, Andersson L, Larhammar D, Rask L, Sigurdardottir S (1994) Simplifying genetic locus assignment of HLA-DRB genes. Immunology Today 15: 58-62.
13. Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, et al. (1993) Promiscuous and allele-specific anchors in HLA-DR-bindig peptides. Cell 74: 197-203.
14. Schafroth HD, Floudas CA (2004) Predicting Peptide Binding to MHC Pockets via Molecular Modeling, Implicit Solvation, and Global Optimization. Proteins 54: 534-556.
15. Stern L, Brown J, Jardetzky T, Gorga J, Urban R, et al. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215-221.
16. Southwood S, Sidney J, Kondo A, del Guercio M, Appella E, et al. (1998) Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires. J Immunol 160: 3363-3373.
17. Khandogin J, York DM (2004) Quantum Descriptors for Biological Macromolecules from Linear-Scaling Electronic Structure Methods. Proteins 56: 724-737.
18. Cárdenas C, Obregón M, Balbín A, Villaveces JL, Patarroyo ME (2007) Wave function analysis of MHC-peptide interactions. J Mol Graph Mode 25: 605-615.
19. Cárdenas C, Ortiz M, Balbín A, Villaveces JL, Patarroyo ME (2005) Allele effects in MHC-peptide interactions: A theoretical analysis of HLA-DRb1*0101-HA and HLA-DRb1*0401-HA complexes. Biochem Biophys Res Commun 330: 1162-1167.
20. Cárdenas C, Villaveces JL, Suárez C, Obregón M, Ortiz M, et al. (2005) A comparative study of MHC Class-II HLA-DRb1*0401-Col II and HLA-DRb1*0101-HA complexes: a theoretical point of view. J Struct Biol 149: 38-52.
21. Cárdenas C, Villaveces JL, Bohórquez H, Llanos E, Suárez C, et al. (2004) Quantum chemical analysis explains hemagglutinin peptide-MHC Class II molecule HLA-DRb1*0101 interactions. Biochem Biophys Res Commun 323: 1265-1277.
22. Balbín A, Cárdenas C, Villaveces JL, Patarroyo ME (2006) A theoretical analysis of HLA-DRâ1*0301-CLIP complex using the first three multipolar moments of the electrostatic field. Biochimie 88: 1307-1311.
23. Smith KJ, Pyrdol J, Gauthier L, Wiley DC, Wucherpfennigs KW (1998) Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein. J Exp Med 188: 1511-1520.
24. Humprey W, Dalke A, Schulten K (1996) VMD-Visual Molecular Dynamics. J Mol Graph 14: 33-38.
25. Cornell W, Cieplak P, Bayly's C, Gould I, Merz K Jr, et al. (1995) A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules. J Am Chem Soc 117: 5179-5197.
26. Dewar M, Zoedisch E, Healy E (1985) AM1: A new general propouse quantum mechanical molecular model. J Am Chem Soc 107: 3902-3909.
27. Gaussian 98, Revision A11, Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, et al. (2001) Pittsburgh, PA: Gaussian, Inc.
28. Batchrach S (1994) Population Analysis and electron densities from quantum mechanics. In: Lipkowitz K, Boyd D, eds. Reviews in computational chemistry. New York: VHC publishers. Vol 5, Chapter 3.
29. Vogt AB, Kropshofer H, Kalbacher H, Kalbus M, Rammensee H, et al. (1994) Ligand Motifs of HLA-DRB5*0101 and DRB1*1501 Molecules Delineated from Self-Peptides. J Immunol 153: 1665-1673.
30. Wucherpfennig KW, Sette A, Southwood S, Oseroff C, Matsui M, et al. (1994) Structural Requirements for Binding of an Immunodominant Myelin Basic Protein Peptide to DR2 Isotypes and for Its Recognition by Human T Cell Clones. J Exp Med 179: 279-290.
31. Krogsgaard M, Wucherpfennig KW, Canella B, Hansen BE, Svejgaard A, et al. (2000) Visualization of Myelin Basic Protein (MBP) T Cell Epitopes in Multiple Sclerosis Lesions using a Monoclonal Antibody Specific for the Human Histocompatibility Leukocyte Antigen (HLA)-DR2-MBP 85-99 Complex. J Exp Med 191: 1395-1412.
32. Tukey JW (1977) Exploratory Data Analysis. Reading, MA: Addison-Wesley.
33. Lund O, Nielsen M, Kesmir C, Petersen AG, Lundegaard C, et al. (2004) Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55: 797-810.
34. Sturniolo T, Bono E, Ding J, Raddrizzani L, Tuereci O, et al. (1999) Generation of tissue-specific and promiscuous HLA ligand databases using DNA micro-arrays and virtual HLA class II matrices. Nat Biotechnol 17: 555.
35. k and the bound peptide to the pH-dependent thermal stability. Microbiol Immunol 48: 53-57.
36. Suárez CF, Patarroyo ME, Trujillo E, Estupiñan M, Baquero JE, et al. (2006) Owl monkey MHC-DRB exon 2 reveals high similarity with several HLA-DRB linages. Immunogenetics 58: 542-558.
37. Sanner MF, Spehner JC, Olson AJ (1996) Reduced surface: an efficient way to compute molecular surfaces. Biopolymers 38: 305-320.